Denis Horvath

Dr. Denis Horvath

Pavol Jozef Šafárik University in Košice, Technology and Innovation Park, Center for Interdisciplinary Biosciences
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2001 in Physica A: Statistical Mechanics and its Applications
Verified
Journal Article
Closed access
OAO.F. Abubrig
O.F. Abubrig
Denis HorvathDenis Horvath
Denis Horvath
ABA. Bobák
A. Bobák
MJM. Jaščur
M. Jaščur

1 April 2002 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
ABA. Bobák
A. Bobák
OAO.F. Abubrig
O.F. Abubrig
Denis HorvathDenis Horvath
Denis Horvath

1 September 2002 in Physica A: Statistical Mechanics and its Applications
Verified
Journal Article
Closed access
ABA. Bobák
A. Bobák
OAO.F. Abubrig
O.F. Abubrig
Denis HorvathDenis Horvath
Denis Horvath

1 January 1997 in Physical Review E
Verified
Journal Article
Closed access
PDF file
JBJ. Busa
J. Busa
MHM. Hnatich
M. Hnatich
JHJuha Honkonen
Juha Honkonen
Denis HorvathDenis Horvath
Denis Horvath
Renormalization-group analysis of randomly stirred fluid with anisotropic distribution of random force is carried out at one-loop order. The axial anisotropy is introduced by free parameters of external forcing in the Navier-Stokes equation, but the anisotropy parameters are not assumed to be small. The region of stability of the Kolmogorov scaling regime in the space of anisotropy parameters has been determined for several space dimensionalities 2 DOI: https://doi.org/10.1103/PhysRevE.55.381 ©1997 American Physical Society

8 August 2022 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
VPViktória Pevná
Viktória Pevná
Denis HorvathDenis Horvath
Denis Horvath
Georges WagnieresGeorges Wagnieres
Georges Wagnieres
Veronika HuntosovaVeronika Huntosova
Veronika Huntosova

Verified
Journal Article
Open access
PDF file
ZMZuzana Majercikova
Zuzana Majercikova
KDKatarína Dibdiaková
Katarína Dibdiaková
MGMichal Gala
Michal Gala
Denis HorvathDenis Horvath
Denis Horvath
RMRadovan Murin
Radovan Murin
JHJozef Hatok
Jozef Hatok
Deregulation of signalling pathways that regulate cell growth, survival, metabolism, and migration can frequently lead to the progression of cancer. Brain tumours are a large group of malignancies characterised by inter- and intratumoral heterogeneity, with glioblastoma (GBM) being the most aggressive and fatal. The present study aimed to characterise the expression of cancer pathway-related genes (n = 84) in glial tumour cell lines (A172, SW1088, and T98G). The transcriptomic data obtained by the qRT-PCR method were compared to different control groups, and the most appropriate control for subsequent interpretation of the obtained results was chosen. We analysed three widely used control groups (non-glioma cells) in glioblastoma research: Human Dermal Fibroblasts (HDFa), Normal Human Astrocytes (NHA), and commercially available mRNAs extracted from healthy human brain tissues (hRNA). The gene expression profiles of individual glioblastoma cell lines may vary due to the selection of a different control group to correlate with. Moreover, we present the original multicriterial decision making (MCDM) for the possible characterization of gene expression profiles. We observed deregulation of 75 genes out of 78 tested in the A172 cell line, while T98G and SW1088 cells exhibited changes in 72 genes. By comparing the delta cycle threshold value of the tumour groups to the mean value of the three controls, only changes in the expression of 26 genes belonging to the following pathways were identified: angiogenesis FGF2; apoptosis APAF1, CFLAR, XIAP; cellular senescence BM1, ETS2, IGFBP5, IGFBP7, SOD1, TBX2; DNA damage and repair ERCC5, PPP1R15A; epithelial to mesenchymal transition SNAI3, SOX10; hypoxia ADM, ARNT, LDHA; metabolism ATP5A1, COX5A, CPT2, PFKL, UQCRFS1; telomeres and telomerase PINX1, TINF2, TNKS, and TNKS2. We identified a human astrocyte cell line and normal human brain tissue as the appropriate control group for an in vitro model, despite the small sample size. A different method of assessing gene expression levels produced the same disparities, highlighting the need for caution when interpreting the accuracy of tumorigenesis markers.